الرئيسية › السرطان (جميع الأنواع) › أوريغون › Portland
التجارب السريرية لـ السرطان (جميع الأنواع) في Portland، OR
34 دراسات لـ السرطان (جميع الأنواع) تبحث عن مشاركين في مواقع داخل وحول Portland (ضمن نطاق 30 ميلًا تقريبًا). افتح الدراسة لمعرفة من يمكنه المشاركة وكيفية التواصل مع فريق الدراسة.
النص الرسمي للدراسة (بالإنجليزية)
تبحث عن مشاركين لدراسة؟ أبرزها في أعلى الصفحة — $99 لمدة 30 يومًا →
A Study to Assess Change in Disease Activity and Adverse Events in Adult Participants With Gynecologic Cancers Receiving Intravenous Infusion of IMGN151 as Monotherapy or in Combination With Other Therapies
جارٍ التسجيلالمرحلة 2
- Providence Portland Medical Center /ID# 277727, Portland
A Study of ASP3082 in Adults With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- Oregon Health and Science University, Portland
A First-in-Human Study of KK2223 in Participants With Relapsed or Refractory T Cell Non-Hodgkin Lymphoma
جارٍ التسجيلالمرحلة 1
- Oregon Health & Science University, Portland
A Study of PHN-012 in Patients With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1
- PHN-012-001 Site, Portland
A Phase 3 Study of Ersodetug in Patients With Tumor Hyperinsulinism
جارٍ التسجيلالمرحلة 3
- Investigative Site, Portland
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
جارٍ التسجيلالمرحلة 2/3
- OHSU Center for Health & Healing 1, Portland
- Oregon Health and Science University, Portland
- OSHU Center for Health and Healing 2, Portland
A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer
جارٍ التسجيلالمرحلة 3
- Oregon Health and Science University /ID# 280071, Portland
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
جارٍ التسجيلالمرحلة 2
- Providence Health & Services, Portland
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
جارٍ التسجيلالمرحلة 2/3
- Providence Portland Medical Center, Portland
- Oregon Health and Science University OHSU, Portland
Connect for Cancer Prevention Study (Connect)
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Kaiser Permanente Northwest, Portland
A Study of Patritumab Deruxtecan in Pediatric Participants With Relapsed or Refractory Solid Tumors (MK-9999-01C/LIGHTBEAM-U01)
جارٍ التسجيلالمرحلة 1/2
- Oregon Health and Science University ( Site 3004), Portland
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
جارٍ التسجيلالمرحلة 1/2
- Oregon Health and Science University /ID# 272282, Portland
A Phase 1/1b Study of IAM1363 in HER2 Cancers
جارٍ التسجيلالمرحلة 1
- Providence Cancer Institute, Portland
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
جارٍ التسجيلالمرحلة 3
- Providence Portland Medical Center, Portland
- Providence St. Vincent Medical Center, Portland
- Kaiser Permanente Interstate Medical Office Central, Portland
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
جارٍ التسجيلالمرحلة 1
- Providence Portland Medical Center, Portland
IMmunotherapy: Prospective Assessment of Cannabis Treatment in Cancer
جارٍ التسجيلدراسة رصدية
- Oregon Health and Science University, Portland
Project: Every Child for Younger Patients With Cancer
جارٍ التسجيلدراسة رصدية
- Legacy Emanuel Children's Hospital, Portland
- Oregon Health and Science University, Portland
FOG-001 in Locally Advanced or Metastatic Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Oregon Health and Science University, Portland
A Master Protocol (LY900023) That Includes Several Clinical Trials of Drugs for Children and Young Adults With Cancer
جارٍ التسجيلالمرحلة 2
- Oregon Health and Science University, Portland
Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer
جارٍ التسجيلالمرحلة 3
- Legacy Good Samaritan Hospital and Medical Center, Portland
- Providence Portland Medical Center, Portland
- Providence Saint Vincent Medical Center, Portland
- و 2 أخرى
Olanzapine for the Management of Cancer Associated Appetite Loss in Patients With Advanced Esophagogastric, Hepatopancreaticobiliary, Colorectal or Lung Cancer
جارٍ التسجيلالمرحلة 2
- OHSU Knight Cancer Institute, Portland
A Study to Assess Adverse Events and Change in Disease Activity in Adult Participants Receiving Intravenously Infused Telisotuzumab Adizutecan Alone or With Standard of Care in Participants With Post Adjuvant Circulating Tumor DNA Positive Colorectal Cancer and No Radiographic Evidence of Disease
جارٍ التسجيلالمرحلة 2
- Northwest Cancer Specialists /ID# 275151, Portland
First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors
جارٍ التسجيلالمرحلة 1/2
- Providence Cancer Institute Franz Clinic, Portland
Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
جارٍ التسجيلالمرحلة 2
- Oregon Health and Science University, Portland
A Study to Evaluate the Safety,Tolerability, Pharmacokinetics and Clinical Activity of Mocertatug Rezetecan for Injection in Participants With Advanced Solid Tumors (BEHOLD-1)
جارٍ التسجيلالمرحلة 1
- GSK Investigational Site, Portland
Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI
جارٍ التسجيل
- VA Portland Health Care System, Portland, OR, Portland
Galleri® in the Medicare Population.
جارٍ التسجيلمرحباً بالمتطوعين الأصحاء
- OHSU CEDAR Clinical Trials Portland, Portland
- OHSU CEDAR Clinical Trials Richmond, Portland
I-SPY TRIAL: Neoadjuvant and Personalized Adaptive Novel Agents to Treat Breast Cancer
جارٍ التسجيلالمرحلة 2
- Oregon Health & Science Institute (OHSU), Portland
CA-4948-101: Open-Label, Dose Escalation and Expansion Trial of Emavusertib (CA-4948) in Relapsed or Refractory Primary Central Nervous System Lymphoma (R/R PCNSL)
جارٍ التسجيلالمرحلة 1/2
- Providence Neurological Specialties West, Portland
Beat Childhood Cancer Specimen Banking and Data Registry
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Randall Children's Hospital, Portland
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
جارٍ التسجيلدراسة رصدية
- Massive Bio SYNERGY-AI site, Portland
Observational Study of Iris Tumors
جارٍ التسجيلدراسة رصديةمرحباً بالمتطوعين الأصحاء
- Oregon Health & Science University, Portland
A Study of GV20-0251 Monotherapy and GV20-0251 in Combination With Pembrolizumab in Participants With Solid Tumor Malignancies
جارٍ التسجيلالمرحلة 1/2
- Oregon Health & Science University, Portland
Melanoma Margins Trial-II: 1cm v 2cm Wide Surgical Excision Margins for AJCC Stage II Primary Cutaneous Melanoma
جارٍ التسجيل
- Kaiser Permanente Northwest - Oncology Clinic, Portland
تجارب السرطان (جميع الأنواع) في مدن أخرى
- Houston, TX121 دراسات
- New York City, NY109 دراسات
- Boston, MA85 دراسات
- Los Angeles, CA74 دراسات
- Nashville, TN65 دراسات
- Philadelphia, PA59 دراسات
- Washington, DC58 دراسات
- Durham, NC58 دراسات
- Chicago, IL51 دراسات
- Atlanta, GA49 دراسات
- Seattle, WA49 دراسات
- Arlington, VA48 دراسات
دراسات أخرى في Portland
- سرطان الرئة غير صغير الخلايا46 دراسات
- سرطان الثدي33 دراسات
- سرطان البروستاتا33 دراسات
- السرطان النقيلي29 دراسات
- سرطان القولون والمستقيم28 دراسات
- سرطان المبيض27 دراسات
- سرطان الرئة26 دراسات
- ابيضاض الدم النقوي الحاد25 دراسات
- سرطان بطانة الرحم24 دراسات
- سرطان الخلايا الحرشفية في الرأس والرقبة19 دراسات
- سرطان البنكرياس19 دراسات
- قصور القلب17 دراسات
من ClinicalTrials.gov، البيانات مستخرجة في 06/10/2026. كل دراسة تحدد معايير أهليتها الخاصة؛ فريق الدراسة هو من يحدد من يمكنه المشاركة.